In January, 2001, the two
mutations that cause FD were identified. These mutations cause
part of the gene to skip, resulting in a shortened form of IKAP
protein. Understanding how the mutation causes the skipping is
necessary for figuring out how to get cells to ignore the skip;
figuring out how to successfully turn off the mutation will
bring about the cure to FD. Such was the goal of Dr. Gil Ast, FD
Hope-funded researcher at Tel Aviv University in Israel, who in
April, 2004 published two articles describing in part how the FD
mutation causes its effect.
Genes and Proteins
Genes are the basic unit of
heredity. Each cell in our bodies contains two copies of
eachofourgenes, one inherited from each parent. Genes are made
up of DNA, chains as beads on a string. They act like templates
for making proteins, the molecules which carry out the work in
cells. A gene has areas that are used to make proteins (exons)
and other areas (introns) that help guide the process of protein
production. Most genes are made up of many exons, separated by
introns.
The steps necessary to
produce a protein from a gene are very complex but consist of
two main steps, known as transcription and translation. The
process of transcription and translation is known as gene
expression. When a gene undergoes transcription, the information
stored in its DNA is transferred to a molecule called RNA
(ribonucleic acid) in the cell nucleus. RNA and DNA are both
chains of nucleotide bases, although they have different
chemical properties. The messenger RNA (mRNA) carries the
information for making a protein out of the cell nucleus, where
the DNA lives, into the main part of the cell where translation
occurs. During the process of creating mRNA, the introns of a
gene are spliced out and the exons are pasted together.
The mRNA combines with a
ribosome complex, which reads the chain of mRNA bases. Proteins
are made up of hundreds or thousands of amino acids, which are
strung together in chains. The ribosome and a second type of RNA
called transfer RNA build the protein one amino acid at a time
by substituting an amino acid for each sequence of three
nucleotide bases (called a codon). The protein is finished when
the ribosome finds a "stop" codon (three base pairs that do not
code for an amino acid).
Familial Dysautonomia
The exact function of the
IKAP protein is not clearly understood, but it is believed to
play a role in transcription and it may also have other
functions in the cell, such as regulating the cell's response to
stress. The "major" or more common mutation in FD is found in an
intron segment of IKBKAP called a donor splice site (5' ss) that
has direct control over the splicing (or cutting) out of introns
and pasting together of exons. Because of the mutation, exon 20
is skipped in the formation of IKAP mRNA. The result is a
shorter and dysfunctional IKAP protein.
The splicing is carried out
by a series of proteins that make up a splicesome complex,
labeled Ul, U2,...U6. These proteins help cut and then paste two
exons together, thus peeling away the unneeded intervening
intron portion.
In FD, some cells are able
to ignore the mutation and produce normal protein, while other
cell types (particularly the autonomic and sensory nervous
systems) end up producing more mutated proteins and only a small
proportion of normal proteins. Determining what controls the
differences in gene expression is essential to controlling the
mutation's effect.
Alu Elements
In the first of his two
papers, Dr. Ast identified some of the factors found in the IKAP
gene which may cause the mutation to have its effect. One such
factor, which seems to influence the function of the IKAP gene
expression in FD, is known as an Alu sequence. Alu elements are
sections of DNA that are found only in primates (man, apes) and
are scattered among introns. Only a small percentage of introns
contain Alu elements and Alu elements are found in different
stages of becoming "exonized" (i.e.. transforming from an Alu
element into an exon).
Because it is nearly an
exon, the Alu element in intron 20 of the FD gene may affect the
binding of the spliceosome complex to the region of the FD
mutation, which may result in the skipping of exon 20. This
finding has significant impact for the study of how genes
produce proteins, particularly in FD. If the nearly exonized Alu
element of intron 20 does indeed influence the effect of the FD
mutation on the 1KAP gene, then Dr. Ast's research suggests that
only primate neurons would be able to fully express FD in the
same manner as humans.
Binding with the
Spliceosome
In his second publication,
Dr. Ast examines how differences in various positions of the
nucleotide bases affect how an exon is spliced. The FD mutation
is found in the 6th position (~6) of intron 20's 5" splice site.
The mutation in this position. in combination with the
nucleotide found in the last position (-1) of exon 20,
negatively affects the binding with the splicesome protein
called Ul. "We found that base-pairing of this position {+6 } to
U1,. . . partially restored the normal splicing of exon 20. . .
.." (Carmel, et al, 2004, p. 834-5)
The FD mutation doesn't
allow the U1 to bind well and the occurrence of an adenosine (A)
nucleotide in the last position of exon 20 contributes to this
inefficient binding. "T-to-C mutation at position +6 on mRNA
splicing of exon 20 implies that it weakens the 5'ss:Ul snRNA
interaction. We then examined whether this weakness could be
related to the presence of adenosine at position -1, which
mispairs with Ul snRNA." (Ibid, p. 835). The researchers tested
this hypothesis by creating a U1 splicesome protein with a
mutation ot match the one found in the FD gene, allowing them to
bind together well. This designer splicesome protein "restored
the splicing of exon 20 in 24% of the splicing events (which is
likely the ratio between endogenous and exogenous Ul)." (Ibid.,
p. 835)
They further evaluated the
influence of the nucleotide base at position -1 by changing the
nucleotide found in that position of the FD mutation (Adenosine
or A) to a more common form (Guanine or G) and found that "...,
a mutation of A to G at position -1 of exon 20 restored normal
splicing of the mRNA derived from the FD mini-gene. ... it shows
that increasing the base-pairing of Ul snRNA to the exonic
portion of the 5'ss can compensate for loss of function due to a
mispair with the intronic portion, which is in agreement with
the exonic-intronic linkage previously shown." (Ibid., p. 835).
In other words, despite the mutation found in intron 20 of IKAP.
other factors can be manipulated to increase the binding of the
Ul splicesome protein, which is needed for normal gene
transcription.
Implications
It is evident from the
pioneering work by FD Hope-funded researchers Drs. Berish Rubin
and Sylvia Anderson of Fordham University's Laboratory for
Familial Dysautonomia Research, that there are substances which
can increase the amount of normal IKAP protein made by a person
with FD. Dr. Ast's research is the first of its kind to
delineate some of the mechanisms by which the mutation produces
its effect on the splicing of exon 20 and to suggest possible
ways to manipulate the mutation so that it does not cause exon
20 skipping. With this first significant step towards a gene
cure, FD Hope is grateful to Dr. Ast and all the members of his
lab who have worked so hard to find answers for our children.